Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00048204 | A Study Of A New Medicine (GW597599B) For The Treatment Of Major Depressive Disorder | PHASE2 | COMPLETED | 372 | — | — | Nov 4, 2002 | Sep 30, 2003 | Oct 9, 2017 | - | — |
| Name | Type | Description |
|---|---|---|
| GW597599B | DRUG | - |
| paroxetine | DRUG | - |
Inclusion Criteria: * Patients meet the diagnosis of Major Depressive Disorder (MDD). Exclusion Criteria: * Patients with a primary diagnosis other than MDD. * Patients with a history of schizophrenia, schizoaffective disorders, seizure disorders or bipolar affective disorder. * Patients receivin...